Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter to the Editor
  • Published:

Colocalization of BCL2-positive and -negative follicular lymphoma

Leukemia volume 28, pages 1368–1370 (2014)Cite this article

Subjects

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

References

  1. Cong P, Raffeld M, Teruya-Feldstein J, Sorbara L, Pittaluga S, Jaffe ES . In situ localization of follicular lymphoma: description and analysis by laser capture microdissection. Blood 2002; 99: 3376–3382.

    Article  CAS  PubMed  Google Scholar 

  2. Schmidt J, Salaverria I, Haake A, Bonzheim I, Adam P, Montes-Moreno S et al. Increasing genomic and epigenomic complexity in the clonal evolution from in situ to manifest t(14;18)-positive follicular lymphoma. Leukemia 2013; (e-pub ahead of print 23 October 2013; doi:10.1038/leu.2013.307.

    Article  PubMed  Google Scholar 

  3. Bonzheim I, Salaverria I, Haake A, Gastl G, Adam P, Siebert R et al. A unique case of follicular lymphoma provides insights to the clonal evolution from follicular lymphoma in situ to manifest follicular lymphoma. Blood 2011; 118: 3442–3444.

    Article  CAS  PubMed  Google Scholar 

  4. Harris NL, Swerdlow SH, Jaffe ES, Ott G, Nathwani BN, de Jong D et al. Follicular lymphoma. In: Swerdlow SH, Campo E, Harris NL, et al eds WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press: Lyon, France, 2008, 220–226.

    Google Scholar 

  5. Leich E, Zamo A, Horn H, Haralambieva E, Puppe B, Gascoyne RD et al. MicroRNA profiles of t(14;18)-negative follicular lymphoma support a late germinal center B-cell phenotype. Blood 2011; 118: 5550–5558.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Masir N, Campbell LJ, Jones M, Mason DY . Pseudonegative BCL2 protein expression in a t(14;18) translocation positive lymphoma cell line: a need for an alternative BCL2 antibody. Pathology 2010; 42: 212–2166.

    Article  CAS  PubMed  Google Scholar 

  7. Adam P, Baumann R, Schmidt J, Bettio S, Weisel K, Bonzheim I et al. The BCL2 E17 and SP66 antibodies discriminate 2 immunophenotypically and genetically distinct subgroups of conventionally BCL2-"negative" grade 1/2 follicular lymphomas. Hum Pathol 2013; 44: 1817–1826.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The study is supported by funds from the Institut Universitaire de France (IUF), ARC and Labex TOUCAN.

Author information

Authors and Affiliations

  1. INSERM, U.1037, Centre de Recherche en Cancérologie de Toulouse, Toulouse, France

    C Laurent & P Brousset

  2. Université Paul-Sabatier, Toulouse, France

    C Laurent & P Brousset

  3. Laboratoire d'Anatomie Pathologique and Labex TOUCAN, CHU Purpan, Toulouse, France

    C Laurent & P Brousset

Authors
  1. C Laurent
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P Brousset
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to P Brousset.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Laurent, C., Brousset, P. Colocalization of BCL2-positive and -negative follicular lymphoma. Leukemia 28, 1368–1370 (2014). https://doi.org/10.1038/leu.2014.45

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/leu.2014.45

Search

Advanced search

Quick links